Bindley Capital Partners I, LLC
CIK: 0002038820
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Guardian Pharmacy Services, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 27, 2026GRDN
Guardian Pharmacy Services, Inc.
Exercise(M)Direct6.1M shares- - Mar 20, 2026GRDN
Guardian Pharmacy Services, Inc.
Sale(S)Direct3.6M shares at avg. $29.68$106.0M - Sep 27, 2025GRDN
Guardian Pharmacy Services, Inc.
Exercise(M)Direct6.1M shares- - May 28, 2025GRDN
Guardian Pharmacy Services, Inc.
Sale(S)Direct651.5K shares at avg. $20.16$13.1M - May 27, 2025GRDN
Guardian Pharmacy Services, Inc.
Sale(S)Direct3.5M shares at avg. $20.16$70.7M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 27, 2026 | GRDN Guardian Pharmacy Services, Inc. | Exercise(M) | 6,100,175 | - | $0 | Direct |
| Mar 20, 2026 | GRDN Guardian Pharmacy Services, Inc. | Sale(S) | 3,570,677 | $29.68 | $105,986,620 | Direct |
| Sep 27, 2025 | GRDN Guardian Pharmacy Services, Inc. | Exercise(M) | 6,100,176 | - | - | Direct |
| May 28, 2025 | GRDN Guardian Pharmacy Services, Inc. | Sale(S) | 651,454 | $20.16 | $13,133,313 | Direct |
| May 27, 2025 | GRDN Guardian Pharmacy Services, Inc. | Sale(S) | 3,508,905 | $20.16 | $70,739,525 | Direct |
1-5 of 5 transactions
About Bindley Capital Partners I, LLC
Bindley Capital Partners I, LLC (SEC CIK 0002038820) files insider reports with the SEC as 10% Owner of Guardian Pharmacy Services, Inc. (GRDN).
Signal8 holds 5 ownership filings by Bindley Capital Partners I, LLC (1 Form 3, 4 Form 4), filed between Apr 1, 2025 and Sep 28, 2026. Those filings report 5 transactions, from May 27, 2025 to Sep 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bindley Capital Partners I, LLC's filings is in INDIANAPOLIS, IN.
Recent filings by Bindley Capital Partners I, LLC
- Sep 27, 2026: Option exercise of GRDN shares (Form 4, code M).
- Mar 20, 2026: Open-market sale of GRDN shares (Form 4, code S).
- Sep 27, 2025: Option exercise of GRDN shares (Form 4, code M).
- May 28, 2025: Open-market sale of GRDN shares (Form 4, code S).
- May 27, 2025: Open-market sale of GRDN shares (Form 4, code S).
Other insiders filing for Guardian Pharmacy Services, Inc. (GRDN)
- Mudd William Franklin
- Weir Robert
- Ackerman John, Director
- Salentine Thomas J Jr, Director
- Martin David Norman
- Pharmacy Investors, LLC, Officer